Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BioVie Inc. stock logo
BIVI
BioVie
$1.14
-4.2%
$0.98
$0.62
$7.50
$21.17M0.771.83 million shs149,870 shs
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
$1.63
+2.5%
$3.55
$1.20
$3.35
$5.32M0.7765,215 shs14,068 shs
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$3.46
+0.6%
$3.11
$2.57
$6.88
$21.37M0.638,985 shs778 shs
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
$2.08
-9.2%
$2.01
$0.12
$10.00
$19.12MN/A625,584 shs51,017 shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BioVie Inc. stock logo
BIVI
BioVie
+7.21%+9.17%+11.21%+10.19%+142.07%
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
-0.63%+4.61%-24.29%-93.49%-94.11%
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
+0.58%+0.85%+4.24%-1.71%-47.72%
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
+9.05%+22.46%+21.42%-35.49%+228,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BioVie Inc. stock logo
BIVI
BioVie
2.4817 of 5 stars
3.83.00.00.02.70.00.6
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
0.8175 of 5 stars
0.05.00.00.02.20.80.0
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
0.7794 of 5 stars
0.03.00.00.01.91.70.6
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
3.825 of 5 stars
3.80.00.00.02.73.31.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BioVie Inc. stock logo
BIVI
BioVie
3.50
Strong Buy$3.00163.16% Upside
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
0.00
N/AN/AN/A
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
0.00
N/AN/AN/A
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
3.50
Strong Buy$10.00380.77% Upside

Current Analyst Ratings Breakdown

Latest CPHI, NAII, BIVI, and SNYR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/18/2025
BioVie Inc. stock logo
BIVI
BioVie
Brookline Capital Management
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BioVie Inc. stock logo
BIVI
BioVie
N/AN/AN/AN/A$2.54 per shareN/A
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
$4.30M1.24N/AN/A$0.70 per share2.33
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
$125.48M0.17N/AN/A$12.77 per share0.27
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
$33.59M0.57N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BioVie Inc. stock logo
BIVI
BioVie
-$32.12M-$7.91N/AN/AN/A-134.07%-93.44%8/21/2025 (Estimated)
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
-$3.08MN/A0.00N/A-85.56%-63.93%-31.42%N/A
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
-$7.22M-$1.39N/AN/A-6.26%-9.36%-4.82%N/A
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
N/AN/A0.003.53N/AN/AN/AN/AN/A

Latest CPHI, NAII, BIVI, and SNYR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
$0.07$0.10+$0.03$0.10$9.03 million$8.17 million
5/14/2025Q3 2025
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
N/A-$0.37N/A-$0.37N/A$28.77 million
5/12/2025Q3 2025
BioVie Inc. stock logo
BIVI
BioVie
-$0.32-$0.15+$0.17-$0.15N/AN/A
3/31/2025Q4 2024
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
$0.10$0.01-$0.09$0.01$10.55 million$10.30 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BioVie Inc. stock logo
BIVI
BioVie
N/AN/AN/AN/AN/A
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
N/AN/AN/AN/AN/A
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
N/AN/AN/AN/AN/A
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BioVie Inc. stock logo
BIVI
BioVie
N/A
16.94
16.94
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
0.22
0.79
0.26
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
0.11
2.70
1.50
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
BioVie Inc. stock logo
BIVI
BioVie
4.59%
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
N/A
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
32.40%
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
BioVie Inc. stock logo
BIVI
BioVie
1018.57 million17.71 millionNo Data
China Pharma Holdings, Inc. stock logo
CPHI
China Pharma
2503.26 million15.92 millionNot Optionable
Natural Alternatives International, Inc. stock logo
NAII
Natural Alternatives International
2906.18 million4.90 millionNot Optionable
Synergy CHC Corp. (Uplisting) stock logo
SNYR
Synergy CHC Corp. (Uplisting)
409.19 millionN/AN/A

Recent News About These Companies

Synergy CHC Announces 7th Quarter of Profitability

New MarketBeat Followers Over Time

Media Sentiment Over Time

BioVie stock logo

BioVie NASDAQ:BIVI

$1.14 -0.05 (-4.20%)
Closing price 04:00 PM Eastern
Extended Trading
$1.14 0.00 (-0.44%)
As of 04:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

China Pharma stock logo

China Pharma NYSE:CPHI

$1.63 +0.04 (+2.52%)
Closing price 04:00 PM Eastern
Extended Trading
$1.61 -0.02 (-1.29%)
As of 04:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. In addition, the company provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. Further it offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.

Natural Alternatives International stock logo

Natural Alternatives International NASDAQ:NAII

$3.45 +0.01 (+0.32%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. The company was founded in 1980 and is headquartered in Carlsbad, California.

Synergy CHC Corp. (Uplisting) stock logo

Synergy CHC Corp. (Uplisting) NASDAQ:SNYR

$2.08 -0.21 (-9.17%)
As of 04:00 PM Eastern

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.